GlassScriptPhysician profile
Christopher M Criscuolo
NPI 1518925114
$2,695.06
in general payments reported to CMS, 2019-2025
15 companies · $591 in 2025
The $591 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $292 · 2020: $43.88 · 2021: $386 · 2022: $395 · 2023: $545 · 2024: $443 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,578.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,238.12 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Collegium Pharmaceutical, INC. | $520.06 | 2019-2025 | Belbuca, Xtampza |
| Vertex Pharmaceuticals Incorporated | $219.33 | 2024-2025 | |
| Protega Pharmaceutials INC | $150.51 | 2025 | Roxybond |
| Abbott Laboratories | $124.74 | 2019 | |
| Arbor Pharmaceuticals, INC. | $104.60 | 2019-2022 | |
| Forte Bio-Pharma LLC | $72.62 | 2022-2025 | Prolate, Nalocet, Tanlor |
| Biodelivery Sciences International, INC. | $70.68 | 2019-2021 | |
| Pfizer INC. | $43.84 | 2019-2023 | |
| Sentynl Therapeutics, INC. | $41.46 | 2019 | |
| Azurity Pharmaceuticals, INC. | $40.66 | 2023-2024 | Horizant, Horizant |
| Lilly USA, LLC | $28.20 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $14.48 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.22 | 2023 | Relistor |
| Shionogi INC | $11.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Criscuolo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.